HHS Proposes Revision to Respirator Certification Fees
The Department of Health and Human Services (HHS) proposes to revise the fee structure established in 42 CFR Part 84 (Part 84), currently used by the National Institute for Occupational Safety and Health (NIOSH), within the Centers for Disease Control and Prevention (CDC) to charge respirator manufacturers for the examination, inspection and testing of respirators which are submitted to NIOSH for the purpose of creating or modifying a certificate of approval.
Existing regulations in Part 84, Subpart C--Fees reflect prices for respirator testing and approval that were promulgated in 1972, and have not kept pace with the actual costs of providing these services that benefit respirator manufacturers. The proposed rule is designed to establish fees for the following:
- reviewing applications submitted to NIOSH
- issuing a certificate of approval
- modifying a certificate of approval
- maintaining a certificate of approval
- performing specific, standard laboratory tests which are requested by applicants
- developing and/or performing novel tests which are required to evaluate respirator performance
- qualifying applicant respirator product sites and quality systems
- verifying quality system performance through site quality audits
- verifying commercially available respirator performance through product quality audits
- replacing testing equipment
- providing and maintaining laboratories and office space.
Â
NIOSH will hold a public meeting to allow stakeholders to present information the impact of an increase on respirator fees on individual respirator manufacturers, the respirator market, or on those industries that rely on NIOSH-approved respiratory equipment. The meeting will be held on April 30, 2013, from 10 a.m. to 4 p.m. EDT, or after the last public commenter has spoken, whichever occurs first. Additional meeting information can be found at: www.cdc.gov/niosh/npptl
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
